Effect of 4-(4-bromophenyl)-5-(3-chlorophenyl)-2,4-dihydro-3H-1,2,4- triazole-3-thione on the anticonvulsant action of different classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model

European Journal of Pharmacology

Volumn 690, Issue 1-3, 2012, Pages 99-106

  Luszczki, Jarogniew J ^a,b   Plech, Tomasz ^a   Wujec, Monika ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Antiepileptic drugs; Maximal electroshock induced seizures; Pharmacokinetic pharmacodynamic interaction

Indexed keywords

4 (4 BROMOPHENYL) 5 (3 CHLOROPHENYL) 2,4 DIHYDRO 3H 1,2,4 TRIAZOLE 3 THIONE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG DOSE COMPARISON; DRUG POTENTIATION; ELECTRIC SHOCK; GRIP STRENGTH; LONG TERM MEMORY; MALE; MOTOR PERFORMANCE; MOUSE; MUSCLE STRENGTH; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; SEIZURE; SEIZURE THRESHOLD;

ANIMALS; ANTICONVULSANTS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BRAIN; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; ELECTROSHOCK; HAND STRENGTH; MALE; MEMORY; MICE; MOTOR ACTIVITY; MUSCLE, SKELETAL; SEIZURES; THIONES; TRIAZOLES;

EID: 84864454210     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.06.023     Document Type: Article

References (30)

1. J.R. Boissier, J. Tardy, and J.C. Diverres A simple novel method to explore tranquilizer activity: the chimney test (in French) Med. Exp. (Basel) 3 1960 81 84
2. H. Byrtus, J. Obniska, A. Czopek, K. Kaminski, and M. Pawlowski Synthesis and anticonvulsant activity of new N-Mannich bases derived from 5-cyclopropyl-5-phenyl- and 5-cyclopropyl-5-(4-chlorophenyl)-imidazolidine-2,4- diones Bioorg. Med. Chem. 19 2011 6149 6156
3. H. Byrtus, J. Obniska, A. Czopek, and K. Kaminski Synthesis and anticonvulsant activity of new n-mannich bases derived from 5-cyclopropyl-5- phenyl-hydantoins Arch. Pharm. (Weinheim). 344 2011 231 241
4. A receptor Neuropharmacology 35 1996 1243 1250
5. A. Gupta, P. Mishra, S.N. Pandeya, S.K. Kashaw, V. Kashaw, and J.P. Stables Synthesis and anticonvulsant activity of some substituted 1,2,4-thiadiazoles Eur. J. Med. Chem. 44 2009 1100 1105
6. J. Jain, Y. Kumar, J. Stables, and R. Sinha Menthone semicarbazides and thiosemicarbazides as anticonvulsant agents Med. Chem. 6 2010 44 50
7. K. Kaminski, S. Rzepka, and J. Obniska Synthesis and anticonvulsant activity of new 1-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]pyrrolidine-2,5-diones Bioorg. Med. Chem. Lett. 21 2011 5800 5803
8. P. Kwan, and M.J. Brodie Early identification of refractory epilepsy N. Engl. J. Med. 342 2000 314 319
9. P. Kwan, and M.J. Brodie Epilepsy after the first drug fails: substitution or add-on? Seizure 9 2000 464 468
10. J.T. Litchfield, and F. Wilcoxon A simplified method of evaluating dose-effect experiments J. Pharmacol. Exp. Ther. 96 1949 99 113
11. W. Löscher, C.P. Fassbender, and B. Nolting The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models Epilepsy Res. 8 1991 79 94
12. J.J. Luszczki, N. Ratnaraj, P.N. Patsalos, and S.J. Czuczwar Isobolographic analysis of interactions between loreclezole and conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model Naunyn Schmiedebergs Arch. Pharmacol. 373 2006 169 181
13. J.J. Luszczki, M. Mohamed, and S.J. Czuczwar 2-phosphonomethyl- pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice Eur. J. Pharmacol. 531 2006 66 73
14. J.J. Luszczki, S.L. Kocharov, and S.J. Czuczwar N-(anilinomethyl)-p- isopropoxyphenylsuccinimide potentiates the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock-induced seizure model Neurosci. Res. 64 2009 267 272
15. J.J. Luszczki, L. Antkiewicz-Michaluk, and S.J. Czuczwar Isobolographic analysis of interactions between 1-methyl-1,2,3,4-tetrahydroisoquinoline and four conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model Eur. J. Pharmacol. 602 2009 298 305
16. J.J. Luszczki, S.L. Kocharov, and S.J. Czuczwar Effect of p-isopropoxyphenylsuccinimide monohydrate on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model Pharmacol. Rep. 62 2010 194 202
17. J.J. Luszczki, J.D. Cioczek, S.L. Kocharov, M. Andres-Mach, M. Kominek, and D. Zolkowska Effects of three N-(carboxyanilinomethyl) derivatives of p-isopropoxyphenylsuccinimide on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model Eur. J. Pharmacol. 648 2010 74 79
18. J.J. Luszczki, M. Kominek, M. Florek-Luszczki, D.A. Tchaytchian, S.L. Kocharov, and D. Zolkowska Influence of N-hydroxymethyl-p- isopropoxyphenylsuccinimide on the anticonvulsant action of different classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model Epilepsy Res. 100 2012 27 36
19. O.A. Meyer, H.A. Tilson, W.C. Byrd, and M.T. Riley A method for the routine assessment of fore- and hindlimb grip strength of rats and mice Neurobehav. Toxicol. 1 1979 233 236
20. P. Morieux, C. Salome, K.D. Park, J.P. Stables, and H. Kohn The structure-activity relationship of the 3-oxy site in the anticonvulsant (R)-N-benzyl 2-acetamido-3-methoxypropionamide J. Med. Chem. 53 2010 5716 5726
21. J. Obniska, K. Kaminski, and I. Chlebek Synthesis and anticonvulsant activity of new spirosuccinimides differently substituted at the imide nitrogen atom Acta Pol. Pharm. 66 2009 663 669
22. T. Plech, M. Wujec, A. Siwek, U. Kosikowska, and A. Malm Synthesis and antimicrobial activity of thiosemicarbazides, s-triazoles and their Mannich bases bearing 3-chlorophenyl moiety Eur. J. Med. Chem. 46 2011 241 248
23. M.A. Rogawski, and C.W. Bazil New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channels Curr. Neurol. Neurosci. Rep. 8 2008 345 352
24. M. Shalini, P. Yogeeswari, D. Sriram, and J.P. Stables Cyclization of the semicarbazone template of aryl semicarbazones: synthesis and anticonvulsant activity of 4,5-diphenyl-2H-1,2,4-triazol-3(4H)-one Biomed. Pharmacother. 63 2009 187 193
25. J.P. Stables, and H.J. Kupferberg The NIH Anticonvulsant Drug Development (ADD) Program: preclinical anticonvulsant screening project G. Avanzini, G. Regesta, P. Tanganelli, M. Avoli, Molecular and Cellular Targets for Anti-epileptic Drugs 1997 John Libbey London 191 198
26. L.J. Stephen, M. Forsyth, K. Kelly, and M.J. Brodie Antiepileptic drug combinations-Have newer agents altered clinical outcomes? Epilepsy Res. 98 2012 194 198
27. K. Unverferth, J. Engel, N. Höfgen, A. Rostock, R. Günther, H.J. Lankau, M. Menzer, A. Rolfs, J. Liebscher, B. Müller, and H.J. Hofmann Synthesis, anticonvulsant activity, and structure-activity relationships of sodium channel blocking 3-aminopyrroles J. Med. Chem. 41 1998 63 73
28. P. Venault, G. Chapouthier, L.P. de Carvalho, J. Simiand, M. Morre, R.H. Dodd, and J. Rossier Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks Nature 321 1986 864 866
29. H.S. White, J.H. Woodhead, K.S. Wilcox, J.P. Stables, H.J. Kupferberg, and H.H. Wolf Discovery and preclinical development of antiepileptic drugs R.H. Levy, R.H. Mattson, B.S. Meldrum, E. Perucca, Antiepileptic Drugs fifth ed. 2002 Lippincott Williams & Wilkins Philadelphia 36 48
30. 2 subunit Proc. Natl. Acad. Sci. USA 91 1994 4569 4573